Actavis, the supplier of generic and branded pharmaceuticals that agreed to acquire Allergan in November in a bid against Valeant Pharmaceuticals, will change its name to Allergan for its portfolio of branded products after the takeover is completed. It will keep the name Actavis for other products and for specific ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.